Target intelligence / Profile preview

Respiratory Syncytial Virus G Glycoprotein (G glycoprotein)

Target
G glycoprotein
Molecular classification
Viral Surface Glycoprotein, Type II transmembrane protein
01

Overview

The Respiratory Syncytial Virus (RSV) G glycoprotein is a major surface protein of the RSV virion, functioning primarily as the viral attachment protein. It mediates the initial binding of RSV to host cells, targeting ciliated epithelial cells in the human respiratory tract. The ectodomain contains two heavily glycosylated mucin-like regions separated by a central conserved, unglycosylated cysteine-rich "noose" stabilized by disulfide bonds. There are hypervariable segments at the C-terminal region of the ectodomain, contributing to antigenic diversity among strains. In immortalized cell lines it binds heparan sulfate proteoglycans (HSPG) and in airway epithelium models it interacts with CX3CR1. Both F and G proteins elicit neutralizing antibody responses during natural infection. G remains an important antigenic target because it acts as a neutralizing antigen and contributes significantly to immune evasion through its variability and heavy glycosylation shield.

Other names
RSV GAttachment protein GG protein
02

Mechanism of action

N/A

03

Biological functions

Viral attachment to host cellsReceptor bindingImmune evasion
04

Disease associations

InfectionRespiratory Syncytial Virus Infection
05

Safety considerations

Antigenic variabilityGlycosylation shielding of epitopes

Beyond the preview

Go deeper on Respiratory Syncytial Virus G Glycoprotein (G glycoprotein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Respiratory Syncytial Virus G Glycoprotein (G glycoprotein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call